Fresenius Medical Care AG (FMCQF) EBIT Margin (2009 - 2025)

Fresenius Medical Care AG (FMCQF) has reported EBIT Margin for 17 consecutive years, with 11.21% the latest figure, recorded in Q4 2025.

• In Q4 2025, EBIT Margin rose 192.0% year-over-year to 11.21%; the TTM figure through Dec 2025 stood at 10.45% (up 125.0% YoY), while the FY2025 annual figure was 9.31%, up 142.0% from the prior year.
• EBIT Margin came in at 11.21% for Q4 2025 at Fresenius Medical Care AG, up from 9.75% in the prior quarter.
• The five-year high for EBIT Margin was 55.4% in Q3 2021, with the low at 6.57% in Q3 2023.
• Average EBIT Margin over 5 years is 23.75%, with a median of 10.48% recorded in 2025.
• Across the five-year window, EBIT Margin slumped 20765 bps in 2021 and surged 1867 bps in 2023, its largest moves.
• Year by year, EBIT Margin stood at 43.76% in 2021, then decreased by 23 bps to 33.52% in 2022, then sank by 73 bps to 9.17% in 2023, then gained by 1 bps to 9.29% in 2024, then rose by 21 bps to 11.21% in 2025.
• According to Business Quant data, EBIT Margin over the past three periods registered 11.21%, 9.75%, and 8.87% for Q4 2025, Q3 2025, and Q2 2025 respectively.